ZIEXTENZO
NDC 61314-866, pegfilgrastim-bmez, injection, from Sandoz Inc.
- Product NDC
- 61314-866
- Status
- Listed
- Labeler
- Sandoz Inc
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761045
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61314-866 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PEGFILGRASTIM6 mg/.6mL
Pharmacologic classes
Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61314-866-02 | 61314086602 | 1 BLISTER PACK in 1 CARTON (61314-866-02) / 1 SYRINGE in 1 BLISTER PACK / .6 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/7dada041-6528-4acf-809c-62d271538c9aMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=61314-866
Use it
Look up 61314-866 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61314-866 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61314-866. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.